Pacira BioSciences Inc. has reported increased revenue and net product sales during the fourth-quarter and full-year 2021, leaving the company in the “strongest financial position” in company history, according to a press release.
Pacira reported a total revenue of $541.5 million in 2021, a 26% increase compared with the $429.6 million reported in 2020. The company also reported a total revenue of $159.2 million in the fourth quarter of 2021, a 22% increase compared with the prior year period.
“The acquisition of Flexion Therapeutics combined with record Exparel sales resulted